Cargando…

MicroRNA-155-5p, Reduced by Curcumin-Re-Expressed Hypermethylated BRCA1, Is a Molecular Biomarker for Cancer Risk in BRCA1-methylation Carriers

Constitutional BRCA1-methylation is a cancer risk factor for breast (BC) and ovarian (OC) cancer. MiR-155, regulated by BRCA1, is a multifunctional microRNA that plays a crucial role in the immune system. The present study assessed the modulation of miR-155-5p expression in peripheral white blood ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Moghrabi, Nisreen, Al-Showimi, Maram, Al-Yousef, Nujoud, AlOtai, Lamya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219443/
https://www.ncbi.nlm.nih.gov/pubmed/37240365
http://dx.doi.org/10.3390/ijms24109021
_version_ 1785049011460243456
author Al-Moghrabi, Nisreen
Al-Showimi, Maram
Al-Yousef, Nujoud
AlOtai, Lamya
author_facet Al-Moghrabi, Nisreen
Al-Showimi, Maram
Al-Yousef, Nujoud
AlOtai, Lamya
author_sort Al-Moghrabi, Nisreen
collection PubMed
description Constitutional BRCA1-methylation is a cancer risk factor for breast (BC) and ovarian (OC) cancer. MiR-155, regulated by BRCA1, is a multifunctional microRNA that plays a crucial role in the immune system. The present study assessed the modulation of miR-155-5p expression in peripheral white blood cells (WBCs) of BC and OC patients and cancer-free (CF) BRCA1-methylation female carriers. Additionally, we investigated the potential of curcumin to suppress miR-155-5p in BRCA1-deficient breast cancer cell lines. MiR-155-5p expression was measured using a stem-loop RT-qPCR method. Gene expression levels were determined using qRT-PCR and immunoblotting. MiR-155-5p was more highly expressed in the BRCA1-hypermethylated HCC-38 and UACC-3199 BC cell lines than in the BRCA1-mutated (HCC-1937) and WT BRCA1 (MDA-MB-321) cell lines. Curcumin suppressed miR-155-5p in the HCC-38 cells but not in the HCC-1937 cells via the re-expression of BRCA1. Elevated levels of miR-155-5p were detected in patients with non-aggressive and localized breast tumors and in patients with late-stage aggressive ovarian tumors, as well as in CF BRCA1-methylation carriers. Notably, IL2RG levels were reduced in the OC and CF groups but not in the BC group. Together, our findings suggest opposing effects of WBC miR-155-5p, according to the cell and cancer type. In addition, the results point to miR-155-5p as a candidate biomarker of cancer risk among CF-BRCA1-methylation carriers.
format Online
Article
Text
id pubmed-10219443
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102194432023-05-27 MicroRNA-155-5p, Reduced by Curcumin-Re-Expressed Hypermethylated BRCA1, Is a Molecular Biomarker for Cancer Risk in BRCA1-methylation Carriers Al-Moghrabi, Nisreen Al-Showimi, Maram Al-Yousef, Nujoud AlOtai, Lamya Int J Mol Sci Article Constitutional BRCA1-methylation is a cancer risk factor for breast (BC) and ovarian (OC) cancer. MiR-155, regulated by BRCA1, is a multifunctional microRNA that plays a crucial role in the immune system. The present study assessed the modulation of miR-155-5p expression in peripheral white blood cells (WBCs) of BC and OC patients and cancer-free (CF) BRCA1-methylation female carriers. Additionally, we investigated the potential of curcumin to suppress miR-155-5p in BRCA1-deficient breast cancer cell lines. MiR-155-5p expression was measured using a stem-loop RT-qPCR method. Gene expression levels were determined using qRT-PCR and immunoblotting. MiR-155-5p was more highly expressed in the BRCA1-hypermethylated HCC-38 and UACC-3199 BC cell lines than in the BRCA1-mutated (HCC-1937) and WT BRCA1 (MDA-MB-321) cell lines. Curcumin suppressed miR-155-5p in the HCC-38 cells but not in the HCC-1937 cells via the re-expression of BRCA1. Elevated levels of miR-155-5p were detected in patients with non-aggressive and localized breast tumors and in patients with late-stage aggressive ovarian tumors, as well as in CF BRCA1-methylation carriers. Notably, IL2RG levels were reduced in the OC and CF groups but not in the BC group. Together, our findings suggest opposing effects of WBC miR-155-5p, according to the cell and cancer type. In addition, the results point to miR-155-5p as a candidate biomarker of cancer risk among CF-BRCA1-methylation carriers. MDPI 2023-05-19 /pmc/articles/PMC10219443/ /pubmed/37240365 http://dx.doi.org/10.3390/ijms24109021 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Al-Moghrabi, Nisreen
Al-Showimi, Maram
Al-Yousef, Nujoud
AlOtai, Lamya
MicroRNA-155-5p, Reduced by Curcumin-Re-Expressed Hypermethylated BRCA1, Is a Molecular Biomarker for Cancer Risk in BRCA1-methylation Carriers
title MicroRNA-155-5p, Reduced by Curcumin-Re-Expressed Hypermethylated BRCA1, Is a Molecular Biomarker for Cancer Risk in BRCA1-methylation Carriers
title_full MicroRNA-155-5p, Reduced by Curcumin-Re-Expressed Hypermethylated BRCA1, Is a Molecular Biomarker for Cancer Risk in BRCA1-methylation Carriers
title_fullStr MicroRNA-155-5p, Reduced by Curcumin-Re-Expressed Hypermethylated BRCA1, Is a Molecular Biomarker for Cancer Risk in BRCA1-methylation Carriers
title_full_unstemmed MicroRNA-155-5p, Reduced by Curcumin-Re-Expressed Hypermethylated BRCA1, Is a Molecular Biomarker for Cancer Risk in BRCA1-methylation Carriers
title_short MicroRNA-155-5p, Reduced by Curcumin-Re-Expressed Hypermethylated BRCA1, Is a Molecular Biomarker for Cancer Risk in BRCA1-methylation Carriers
title_sort microrna-155-5p, reduced by curcumin-re-expressed hypermethylated brca1, is a molecular biomarker for cancer risk in brca1-methylation carriers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219443/
https://www.ncbi.nlm.nih.gov/pubmed/37240365
http://dx.doi.org/10.3390/ijms24109021
work_keys_str_mv AT almoghrabinisreen microrna1555preducedbycurcuminreexpressedhypermethylatedbrca1isamolecularbiomarkerforcancerriskinbrca1methylationcarriers
AT alshowimimaram microrna1555preducedbycurcuminreexpressedhypermethylatedbrca1isamolecularbiomarkerforcancerriskinbrca1methylationcarriers
AT alyousefnujoud microrna1555preducedbycurcuminreexpressedhypermethylatedbrca1isamolecularbiomarkerforcancerriskinbrca1methylationcarriers
AT alotailamya microrna1555preducedbycurcuminreexpressedhypermethylatedbrca1isamolecularbiomarkerforcancerriskinbrca1methylationcarriers